Exclusive: ACR Convergence 2024 | Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Conditions
FocusRheum
Guidance
Drug Updates
- Analgesics
- Biologics/DMARDs
Practice Support
- Billing/Coding
- EMRs
- Facility
- Insurance
- QA/QI
- Technology
- Workforce
Opinion
Career
ACR
Search

New Therapeutics for Osteoarthritis May Be in Sight

Antonios Aliprantis, MD, PhD | Issue: April 2015 | April 1, 2015

Page: 1 2 3 4 5 6 7 | Single Page

Share:

Filed under:Conditions Drug Updates Osteoarthritis and Bone Disorders Research Rheum Tagged with:discovery joint degeneration Osteoarthritis Pain Pathogenesis Research Treatment

Related Articles

Cellular Therapy of Autoimmune Disease

November 1, 2008

Is a novel treatment breakthrough on the horizon?

Can Lubricating Joints Prevent Osteoarthritis?

June 13, 2013

Proteoglycan 4 (Prg4), also known as lubricin, could slow the process of cartilage destruction in osteoarthritis. (posted June 13, 2013)

Basics of Biologic Joint Reconstruction

April 6, 2012

For young patients especially, this can delay knee replacement and provide better outcomes.

Lab Study Suggests Zinc May Worsen Rheumatoid Arthritis

January 22, 2022

NEW YORK (Reuters Health)—Zinc supplementation may exacerbate rheumatoid arthritis (RA), new laboratory data suggest. In monocytes from patients with RA, researchers found high concentrations of intracellular zinc, which regulates immune responses by affecting signaling pathways, according to a report in Science Signaling.1 ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEThey also found increased expression of Zip8, a zinc-specific…

About Us
Meet the Editors
Issue Archives
Contribute
Advertise
Contact Us

Copyright © 2000-2024 American College of Rheumatology. All rights reserved. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
DEI Statement
Privacy Policy
Terms of Use
Cookie Preferences